Nine out of 10 patients treated with the experimental therapy saw their tumors shrink
April 13, 2018
| By Rachel Tompa / Fred Hutch News Service
When you look at Carla Stone, you might not guess that she was diagnosed with stage 4 head and neck cancer just two years ago. Stone participated in a clinical trial that shrank her advanced tumor down to nothing, allowing her to undergo a minimally invasive surgery.
Canadian oncologist brings phase 1 expertise to Clinical
May 24, 2010
| By Colleen Steelquist
Dr. Laura Chow, an oncologist from Ontario with experience directing phase 1 clinical trials, has joined the Fred Hutchinson Cancer Research Center Clinical Research Division. At the Seattle Cancer Care Alliance, she will treat lung, head and neck and esophageal cancer patients.
Fred Hutch is proud to be an Equal Opportunity and VEVRAA Employer. We are committed to cultivating a workplace in which diverse perspectives and experiences are welcomed and respected. We do not discriminate on the basis of race, color, religion, creed, ancestry, national origin, sex, age, disability, marital or veteran status, sexual orientation, gender identity, political ideology, or membership in any other legally protected class. We are an Affirmative Action employer. We encourage individuals with diverse backgrounds to apply and desire priority referrals of protected veterans. Read the EEO is the Law poster here.